Neuralink implanted its first human brain-computer interface in Noland Arbaugh in January 2024. By its own January 2026 update, the company reported 20 implant…
Noland Arbaugh, paralyzed below the shoulders by a spinal-cord injury, received Neuralink's first human implant under the PRIME Study, aiming to let him control a comput…
Some of Noland Arbaugh's implanted threads retracted from brain tissue, reducing usable neural signal and initial BCI performance. Neuralink disclosed this publicly and…
A second PRIME participant, Alex, living with a spinal-cord injury, was implanted in July 2024 (announced 21 August 2024). By day two he was using Fusion 360 CAD softwar…
The FDA granted Neuralink's experimental Blindsight program Breakthrough Device Designation, offering a more interactive, expedited review pathway. This is not FDA appro…
Brad Smith became Neuralink's third participant and first with ALS, later communicating via an AI-generated voice. The same month, Health Canada approved CAN-PRIME (20 N…
Neuralink announced UAE-PRIME on 14 May 2025 at Cleveland Clinic Abu Dhabi, evaluating the N1 implant and R1 robot in adults with severe motor and speech impairment from…
GB-PRIME launched 31 July 2025 at University College London Hospitals and Newcastle Hospitals, approved by the MHRA, HRA and Health and Care Research Wales. By December…
Neuralink's official update reported 20 cumulative implantation surgeries through end-2025 (1 in H1'24, 2 in H2'24, 4 in H1'25, 13 in H2'25) and 21 Neuralnauts enrolled…
By mid-2026, public reporting and community participant tracking — not an official Neuralink figure — put the total at at least 26, including a reported first through-th…
Read the complete story, FAQs and key facts.